Cargando…
Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood–brain barrier permeability: a preclinical systematic review and meta-analysis
To achieve sufficient blood–brain barrier (BBB), penetration is one of the biggest challenges in the development of diagnostic and therapeutic for central nervous system (CNS) disorders. Here, we conducted a systematic review and meta-analysis to assess the preclinical evidence and possible mechanis...
Autores principales: | Zheng, Qun, Chen, Zi-Xian, Xu, Meng-Bei, Zhou, Xiao-Li, Huang, Yue-Yue, Zheng, Guo-Qing, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225363/ https://www.ncbi.nlm.nih.gov/pubmed/30334462 http://dx.doi.org/10.1080/10717544.2018.1486471 |
Ejemplares similares
-
Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability
por: Zhang, Qun-Lin, et al.
Publicado: (2017) -
Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism
por: Chen, Zi-xian, et al.
Publicado: (2019) -
Borneol and Α-asarone as adjuvant agents for improving blood–brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors
por: Wu, Jun-Yong, et al.
Publicado: (2018) -
Enhanced permeability of blood–brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle
por: Song, Hui, et al.
Publicado: (2018) -
Design, characterization and comparison of transdermal delivery of colchicine via borneol-chemically-modified and borneol-physically-modified ethosome
por: Zhang, Yujia, et al.
Publicado: (2019)